Reva Medical Inc. announced that it has initiated patient enrollment with its ReZolve2 bioresorbable sirolimus-eluting coronary scaffold.

Lantheus Medical Imaging Inc. announced a new supply contract with the Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for use in its TechneLiteĀ (Technetium Tc 99m Generator) generators.

Two new 1.5T MRI scanners from GE Healthcare, the Optima MR360 Advance and Brivo MR355 Inspire, have recently received 510(k) clearance. Redesigned with new enclosures symbolizing GE’s Humanizing MRI strategy, both systems are engineered to address the demand for increased performance and reduced total cost of ownership for the facility, while providing a comfortable experience for the patient.

The American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. Fourth in the list, they ask that patients and their doctors talk about the real need for a stress echocardiogram if they do not present conditions that would warn them of a risk of heart disease.


Rox Medical announced enrollment of the first U.K. patients in the CONTROL-HTN international randomized controlled trial of the Rox Flow procedure for the treatment of resistant hypertension.


Subscribe Now